Site, histological type, and thickness of primary cutaneous malignant melanoma in western Netherlands since 1980

British Journal of Dermatology

Volumn 136, Issue 4, 1997, Pages 565-571

  Van Der Spek Keijser, L M T ^a,c   Van Der Rhee, H J ^b,c   Toth G ^a   Van Westering, R ^c   Bruijn, J A ^a,c   Coebergh, J W W ^a,c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEYENBURG HOSPITAL   (Netherlands)

^c CCCW Stud Grp for Dermato oncology   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MELANOMA; NETHERLANDS; PRIORITY JOURNAL; SKIN CANCER;

EID: 0030975216     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1997.d01-1236.x     Document Type: Article

References (30)

1. Krol S, Keijser LMT, Rhee HJ van der et al. Screening for skin cancer in the Netherlands. Acta Derm Venereol (Stockh) 1991; 71(4): 317-21.
2. Spek-Keijser LMT van der, Rhee HJ van der, Hartevelt HM et al. Screening for skin cancer: differences in yield between a self-selected and a nonselected population. Cancer Prev Int 1994; 1: 89-93.
3. Spek-Keijser LMT van der, Rhee HJ van der, Bergman W et al. Screening for skin cancer: differences in risk factors between a self-selected and a nonselected population. Cancer Prev Int 1994; 1: 83-8.
4. Bosch MMC, Dutrieux RP, Boon ME et al. Gunstige verschuiving in de melanoomdiagnostiek sinds de 'sproetenbus'campagne, PALGA-gegevens anders bekeken. Med Contact 1990; 45: 906.
5. Coebergh JWW, van der Heijden LH, Janssen-Heijnen MLG. Cutaneous melanoma. In: Cancer Incidence and Survival in the Southeast of the Netherlands, 1955-1994. (Coebergh JWW, van der Heijden LH, Janssen-Heijnen MLG, eds). Eindhoven: Comprehensive Cancer Centre South (IKZ). 1995; 48-50.
6. Tersmette AC, Coebergh JWW, Casparie-Velsen van IJA et al. Invasive cutaneous melanoma in The Netherlands. 1989-1990. Eur J Cancer Prev 1996; 5: 69-74.
7. Lund CC, Browder NC. The estimation of area of burns. Surg Gynecol Obstet 1944; 79: 352-61.
8. MacKie RM, Hunter JAA, Aitchison TC et al. Cutaneous malignant melanoma. Scotland. 1979-89. Lancet 1992; 339: 971-5.
9. Magnus K. Habits of sun exposure and risk of malignant melanoma: an analysis of incidence rates in Norway 1955-1977 by cohort, sex, age, and primary tumor site. Cancer 1981; 48: 2329-35.
10. Lee JAH, Storer BK. Excess of malignant melanoma in women in the British Isles. Lancet 1980; ii: 1737-9.
11. Urist MM, Hynds Karnell L. The National Cancer Data Base: report on melanoma. Cancer 1994; 74: 782-8.
12. Chen YT, Zheng T, Holford R et al. Malignant melanoma incidence in Connecticut (United States): time trends and age-period-cohort modeling by anatomic site. Cancer Causes Control 1994; 5: 341-50.
13. Bell M, Beyl CM, Schopf RE et al. Light exposure of the lower leg as a pathogenetic factor in the occurrence of malignant melanoma. Dermatology 1992; 185: 257-61.
14. Stidham KR, Johnson JL, Seigler HV. Survival superiority of females with melanoma. A multivariate analysis of 6383 patients exploring the significance of gender in prognostic outcome. Arch Surg 1994; 129: 516-24.
15. MacLennan R, Green AC, McLeod GRC et al. Increasing incidence of cutaneous melanoma in Queensland, Australia. J Natl Cancer Inst 1992; 84: 1427-32.
16. Heenan PJ, English DR, Holman CDAJ et al. Survival among patients with clinical stage I cutaneous malignant melanoma diagnosed in Western Australia in 1975/1976 and 1980/1981. Cancer 1991; 68: 2079-87.
17. Thörn M, Pontén F, Bergström R et al. Trends in tumour characteristics and survival of malignant melanoma 1960-84: a population-based study in Sweden. Br J Cancer 1994; 70: 743-48.
18. Garbe C, Büttner P, Ellwanger U et al. The central malignant melanoma registry of the German Dermatological Society 1983 to 1993. Epidemiological trends and current treatment of cutaneous melanoma. Hautarzt 1995; 46: 683-92.
19. Crombie IK. Distribution of malignant melanoma on the body surface. Br J Cancer 1981; 43: 842-9.
20. Østerlind A, Hou-Jensen K, Møller Jensen O. Incidence of cutaneous malignant melanoma in Denmark 1978-82. Anatomic site distribution, histologic types, and comparison with non-melanoma skin cancer. Br J Cancer 1988; 58: 385-91.
21. Batch CM, Soong SJ, Murad TM et al. A multifactorial analysis of melanoma: II. Prognostic factors in patients with stage I (localized) melanoma. Surgery 1979; 86: 343-51.
22. O'Doherty CJ, Prescott RJ, White H et al. Sex differences in presentation of cutaneous malignant melanoma and in survival from stage I disease. Cancer 1986; 58: 788-92.
23. Teppo L, Pakkanen M, Hakulinen T. Sunlight as a risk factor of malignant melanoma. Cancer 1978; 41: 2018-27.
24. Pearl DK, Scott EL. The anatomical distribution of skin cancers. Int J Epidemiol 1986; 15: 502-6.
25. Green A, MacLennan R, Youl P et al. Site distribution of cutaneous melanoma in Queensland. Int J Cancer 1993; 53: 232-6.
26. Osterlind A, Engholm G, Moller Jensen O. Trends in cutaneous melanoma in Denmark 1943-1982 by anatomic site. APMIS 1988; 96: 953-63.
27. Bennett DR, Wasson D, MacArthur JD, McMillen MA. The effect of misdiagnosis and delay in diagnosis on clinical outcome in melanomas on the foot. J Am Coll Surg 1994; 179: 279-84.
28. Singletary SE, Balch CM. Malignant melanoma. In: American Cancer Society Textbook of Clinical Oncology. (Holleb AI, Fink DJ, Murphy GP, eds). Atlanta: The American Cancer Society. Inc., 1991: 263-70.
29. Sondergaard L, Olsen G. Malignant melanoma of the foot. Acta Pathol Scand 1980; 88: 275-83.
30. Thune I, Olsen A, Albrektsen G et al. Cutaneous malignant melanoma: association with height, weight and body-surface area. A prospective study in Norway. Int J Cancer 1993; 55: 555-61.